Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
HilleVax, Inc. - Common Stock
(NQ:
HLVX
)
13.61
-0.41 (-2.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HilleVax, Inc. - Common Stock
< Previous
1
2
Next >
HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023
March 20, 2024
HLVX stock results show that HilleVax beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: HilleVax Q4 Earnings
March 20, 2024
Via
Benzinga
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
March 20, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
February 05, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
January 18, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
January 13, 2024
Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will...
Via
Talk Markets
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
January 08, 2024
Collaboration leverages HilleVax’s leading norovirus vaccine development expertise and adds a Phase 1-ready next-generation program to HilleVax’s pipeline
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 09, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Present at Upcoming Investor Conferences
November 01, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
September 26, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 25, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
Why HilleVax Shares Are Trading Lower
September 20, 2023
HilleVax Inc (NASDAQ: HLVX) shares are trading lower by 8.5% to $13.20 Wednesday morning after the company announced pricing of its previously-announced public offering of comm
Via
Benzinga
HilleVax Announces Pricing of Public Offering of Common Stock
September 19, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 19, 2023
Via
Benzinga
HilleVax Announces Proposed Public Offering of Common Stock
September 19, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 14, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 12, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of Directors
May 09, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine Candidate
April 25, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports Full Year 2022 Financial Results and Highlights Recent Company Progress
March 17, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Executive Management Appointments and Promotions
January 09, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Announces Positive Immunogenicity Results for Run-In Cohort of NEST-IN1 Phase 2b Clinical Trial of HIL-214 Norovirus Vaccine Candidate
December 05, 2022
From
HilleVax, Inc.
Via
GlobeNewswire
Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday
November 22, 2022
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
HilleVax to Participate in November Investor Conferences
November 10, 2022
From
HilleVax, Inc.
Via
GlobeNewswire
HilleVax Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
November 10, 2022
From
HilleVax, Inc.
Via
GlobeNewswire
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
October 26, 2022
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 21, 2022
Gainers
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.